These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 6014083)

  • 1. [Differences in the pharmacological effect of hallucinogenic and von-hallucinogenic lysergic acid derivatives (LSD 25, deseril, lysenyl, mesenyl)].
    Votava Z; Podvalová I; Vojtĕchovský M
    Arzneimittelforschung; 1966 Feb; 16(2):220-2. PubMed ID: 6014083
    [No Abstract]   [Full Text] [Related]  

  • 2. Quantum chemical studies on drug actions. 3. Correlation of hallucinogenic and anti-serotonin activity of lysergic acid derivatives with quantum chemical data.
    Kumbar M; Sankar DV
    Res Commun Chem Pathol Pharmacol; 1973 Jul; 6(1):65-100. PubMed ID: 4734018
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hallucinogenic drugs and the psychopharmacology of the conditioned reflex].
    Sivadjian J
    Therapie; 1970; 25(6):1059-66. PubMed ID: 5509533
    [No Abstract]   [Full Text] [Related]  

  • 4. Hallucinogenic spatial disorientation.
    Cohen LA
    Int J Neuropsychiatry; 1965 Aug; 1(4):347-51. PubMed ID: 4955762
    [No Abstract]   [Full Text] [Related]  

  • 5. Hallucinogenic compounds and swimming response.
    Uyeno ET
    J Pharmacol Exp Ther; 1968 Jan; 159(1):216-21. PubMed ID: 5643945
    [No Abstract]   [Full Text] [Related]  

  • 6. Further evidence that the delayed temporal dopaminergic effects of LSD are mediated by a mechanism different than the first temporal phase of action.
    Marona-Lewicka D; Nichols DE
    Pharmacol Biochem Behav; 2007 Oct; 87(4):453-61. PubMed ID: 17618679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [LSD-25 and UML decrease the levels of 5-hydroxyindoleacetic acid in the brain of rat].
    Torre M; Bogetto F; Torre E
    Boll Soc Ital Biol Sper; 1976 Nov; 52(21):1835-7. PubMed ID: 1026256
    [No Abstract]   [Full Text] [Related]  

  • 8. The use of drug discrimination procedures to characterize hallucinogenic drug actions.
    Appel JB; Cunningham KA
    Psychopharmacol Bull; 1986; 22(3):959-67. PubMed ID: 3797596
    [No Abstract]   [Full Text] [Related]  

  • 9. Stimulus properties of phenethylamine hallucinogens and lysergic acid diethylamide: the role of 5-hydroxytryptamine.
    Winter JC
    J Pharmacol Exp Ther; 1978 Feb; 204(2):416-23. PubMed ID: 621672
    [No Abstract]   [Full Text] [Related]  

  • 10. Molecular modeling of the interaction of LSD and other hallucinogens with 5-HT2 receptors.
    Westkaemper RB; Glennon RA
    NIDA Res Monogr; 1994; 146():263-83. PubMed ID: 8742803
    [No Abstract]   [Full Text] [Related]  

  • 11. LSD, psychotogenic procedures, and brain neurohumors.
    Freedman DX
    Psychopharmacol Bull; 1975 Apr; 11(2):42-3. PubMed ID: 237298
    [No Abstract]   [Full Text] [Related]  

  • 12. The psychopharmacology of hallucinogenic agents.
    Freedman DX
    Annu Rev Med; 1969; 20():409-18. PubMed ID: 4894506
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hawaiian baby woodrose: (Psycho-) Pharmacological effects of the seeds of Argyreia nervosa. A case-orientated demonstration].
    Borsutzky M; Passie T; Paetzold W; Emrich HM; Schneider U
    Nervenarzt; 2002 Sep; 73(9):892-6. PubMed ID: 12215884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substituted naphthofurans as hallucinogenic phenethylamine-ergoline hybrid molecules with unexpected muscarinic antagonist activity.
    Monte AP; Marona-Lewicka D; Lewis MM; Mailman RB; Wainscott DB; Nelson DL; Nichols DE
    J Med Chem; 1998 Jun; 41(12):2134-45. PubMed ID: 9622555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LSD and JB 318: a comparison of two hallucinogens. III. Qualatative analysis and summary of findings.
    LEBOVITS BZ; VISOTSKY HM; OSTEFELD AM
    Arch Gen Psychiatry; 1962 Jul; 7():39-45. PubMed ID: 14463342
    [No Abstract]   [Full Text] [Related]  

  • 16. Acute effects of lysergic acid diethylamide (LSD) on resting brain function.
    Müller F; Borgwardt S
    Swiss Med Wkly; 2019 Sep; 149():w20124. PubMed ID: 31568558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LSD and other related hallucinogens elicit myoclonic jumping behavior in the guinea pig.
    Carvey P; Nausieda P; Weertz R; Klawans H
    Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13(1-2):199-210. PubMed ID: 2748860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LSD and JB 318: a comparison of two hallucinogens. I. An exploratory study.
    LEBOVITS BZ; VISOTSKY HM; OSTFELD AM
    AMA Arch Gen Psychiatry; 1960 Apr; 2():390-407. PubMed ID: 14415046
    [No Abstract]   [Full Text] [Related]  

  • 19. An electrographic study of d-lysergic acid diethylamide and nine congeners.
    Schweigerdt AK; Stewart AH; Himwich HE
    J Pharmacol Exp Ther; 1966 Mar; 151(3):353-9. PubMed ID: 5938474
    [No Abstract]   [Full Text] [Related]  

  • 20. A common mechanism for lysergic acid, indolealkylamine and phenethylamine hallucinogens: serotonergic medication of behavioral effects in rats.
    Sloviter RS; Drust EG; Damiano BP; Connor JD
    J Pharmacol Exp Ther; 1980 Aug; 214(2):231-8. PubMed ID: 6104720
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.